Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q2 2018 13F Holders as of 30 Jun 2018
- Security type / class
- Equity / Common Stock, Par Value $0.001 per share
- Total 13F shares
- 54,418,427
- Total 13F value
- $4,583,658,355
- Share change
- -417,281
- Put/Call ratio
- 59%
- SEC-reported price per share
- $84.23
- Number of holders
- 207
- Value change
- -$33,625,899
- Number of buys
- 112
- Number of sells
- 75
- Shares outstanding
- 59,431,072
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2018
Institutions
207
Top holders
10
AGIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2018
Previous quarter: Q1 2018
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Ownership snapshot
Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2018
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
14%
WELLINGTON MANAGEMENT GROUP LLP
13%
VANGUARD GROUP INC
6.7%
BlackRock Finance, Inc.
5.4%
PRICE T ROWE ASSOCIATES INC /MD/
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
14%
|
$703,227,000
8,599,011 shares
|
— | 31 Mar 2018 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
13%
|
$635,616,000
7,772,274 shares
|
— | 31 Mar 2018 |
| VANGUARD GROUP INC |
13F
Company
|
6.7%
|
$327,155,000
4,000,421 shares
|
— | 31 Mar 2018 |
| BlackRock Finance, Inc. |
13F
Company
|
5.4%
|
$262,192,000
3,206,053 shares
|
— | 31 Mar 2018 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
5.3%
|
$255,646,000
3,126,023 shares
|
— | 31 Mar 2018 |
| Capital International Investors |
13F
Company
|
4.7%
|
$230,806,000
2,822,284 shares
|
— | 31 Mar 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
207
Shares
54,418,427
Rows available
207
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
192
Q2 2018 holders
207
Holder diff
15
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q2 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend